Harrow (HROW) Gross Margin (2013 - 2026)

Harrow (HROW) recorded quarterly Gross Margin of 61.18% in Q1 2026, down 22.82% quarter-over-quarter from 79.27% in Q4 2025, and down 636.0% on a YoY basis from 11.41% in Q1 2025.

Harrow (HROW) Gross Margin (2013 - 2026) Analysis & Trends

Harrow's Gross Margin history runs 14 years deep, the most recent figure standing at 61.18% for Q1 2026.

  • In Q1 2026, Gross Margin fell 636.0% year-over-year to 61.18%; the TTM figure through Mar 2026 stood at 74.11% (down 42.0% YoY), while the FY2025 annual figure was 75.05%, down 28.0% from the prior year.
  • Gross Margin was 61.18% for Q1 2026 at Harrow, down from 79.27% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 79.27% in Q4 2025 to a low of 61.18% in Q1 2026.
  • Historically, Gross Margin has averaged 71.73% across 5 years, with a median of 70.62% in 2023.
  • The sharpest annual moves came in 2024 and 2026: Gross Margin soared 994 bps in 2024, then sank 636 bps in 2026.
  • A 5-year view of Gross Margin shows it stood at 69.67% in 2022, then retreated by 1 bps to 68.91% in 2023, then grew by 14 bps to 78.85% in 2024, then rose by 1 bps to 79.27% in 2025, then fell by 23 bps to 61.18% in 2026.
  • The last three Gross Margin figures came in at 61.18% (Q1 2026), 79.27% (Q4 2025), and 75.28% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 49.52%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 71.66%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 82.93%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 49.50%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 98.31%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.26%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -293.83%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 61.20%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 65.25%
10 Harrow 1.23 Bn 1.14 Bn 27.05 Mn 61.18%

Historic Data

Download Data
DateValue
Mar 31, 2026 61.18%
Dec 31, 2025 79.27%
Sep 30, 2025 75.28%
Jun 30, 2025 74.54%
Mar 31, 2025 67.54%
Dec 31, 2024 78.85%
Sep 30, 2024 75.60%
Jun 30, 2024 74.38%
Mar 31, 2024 69.49%
Dec 31, 2023 68.91%
Sep 30, 2023 70.62%
Jun 30, 2023 70.12%
Mar 31, 2023 68.31%
Dec 31, 2022 69.67%
Sep 30, 2022 70.55%
Jun 30, 2022 71.98%
Mar 31, 2022 73.04%
Dec 31, 2021 74.84%
Sep 30, 2021 73.56%
Jun 30, 2021 75.64%